Our coverage is unrivalled in its depth, geographic scope and local insights. We enable you to make informed and strategic decisions in an ever-changing and highly competitive market.
Our medical device intelligence covers 16 key therapy areas and is available through comprehensive device modules to offer clients complete flexibility of choice.
We produce thousands of quantitative and qualitative reports annually, instantly available, to help you make more informed decisions quickly.
Our Intelligence Centers offer constantly updated data, investigative news, analysis and tools that slot seamlessly into your workflow to help you decode the future.
For fully bespoke independent insight with dedicated expert service, our consulting offering combines global capabilities with strong understanding of your local markets.
On Wednesday (18 July) the FDA unveiled the ‘Biosimilar Action Plan’ (BAP), which aims to promote the development and accessibility of biosimilars in the US healthcare market.
Rahael Maladwala, ...
Following the news (Tuesday 17th July) that J&J’s HIV therapeutic, Symtuza, has been granted marketing approval by the FDA,
Tom Moore, Senior Healthcare Analyst at GlobalData, a leading data...
A long sought after objective of healthcare is to ensure that each patient receives tailored treatment for their medical situation; and now, with the use of big data and newly developed algorithms ...
contact online email@example.com
EMEA: +44 207 832 4399
APAC: +91 40 6616 6809
© GlobalData Plc 2018 | Registered Office: John Carpenter House, John Carpenter Street, London, EC4Y 0AN, UK Registered in England No. 03925319